PB2021: PHASE 2 STUDY OF ORAL DECITABINE/CEDAZURIDINE IN COMBINATION WITH MAGROLIMAB FOR PREVIOUSLY UNTREATED SUBJECTS WITH INTERMEDIATE TO VERY HIGH-RISK MYELODYSPLASTIC SYNDROMES...

por Zeidan, Amer M., Mosher, Karen, Souza, Sonia, Mirakhur, Beloo, Keer, Harold, Taylor, Jason
Publicado 2023

Novel Tumor Growth Rate Analysis in the Randomized CLARINET Study Establishes the Efficacy of Lanreotide Depot/Autogel 120 mg with Prolonged Administration in Indolent Neuroendocri...

por Dromain, Clarisse, Loaiza‐Bonilla, Arturo, Mirakhur, Beloo, Beveridge, Thomas J.R., Fojo, Antonio Tito
Publicado 2021

Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitals

por Ortendahl, Jesse D, Pulgar, Sonia J, Mirakhur, Beloo, Cox, David, Bentley, Tanya GK, Phan, Alexandria T
Publicado 2017

A Patient-Reported Outcomes Analysis Of Lanreotide In The Treatment Of NETs Patients With Carcinoid Syndrome: Evidence From The ELECT Trial

por Blot, Koenraad, Duchateau, Luc, Lescrauwaet, Benedicte, Liyanage, Nilani, Ray, David, Mirakhur, Beloo, Vinik, Aaron I
Publicado 2019

Treatment Outcomes in Patients with Metastatic Neuroendocrine Tumors: a Retrospective Analysis of a Community Oncology Database

por Fisher, Maxine D., Pulgar, Sonia, Kulke, Matthew H., Mirakhur, Beloo, Miller, Paul J., Walker, Mark S., Schwartzberg, Lee S.
Publicado 2018

Screening for comorbid conditions in patients enrolled in the SODA registry: a 2-year observational analysis

por Woodmansee, Whitney W., Gordon, Murray B., Molitch, Mark E., Ioachimescu, Adriana G., Carver, Don W., Mirakhur, Beloo, Cox, David, Salvatori, Roberto
Publicado 2018

Nomogram for Predicting Survival in Patients Treated with Liposomal Irinotecan Plus Fluorouracil and Leucovorin in Metastatic Pancreatic Cancer

por Chen, Li-Tzong, Macarulla, Teresa, Blanc, Jean-Frédéric, Mirakhur, Beloo, de Jong, Floris A., Belanger, Bruce, Bekaii-Saab, Tanios, Siveke, Jens T.
Publicado 2019

P735: EFFICACY AND SAFETY OF ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN THE CMML SUBPOPULATION FROM PHASE 2 AND ASCERTAIN PHASE 3 STUDIES

por Robert Savona, Michael, K Mccloskey, James, A. Griffiths, Elizabeth, Yee, Karen, M. Zeidan, Amer, Al-Kali, Aref, Joachim Deeg, H., A. Patel, Prapti, Sabloff, Mitchell, Keating, Mary-Margaret, Y Zhu, Nancy, Gabrail, Nashat, Fazal, Salman, J. Maly, Joseph, Odenike, Olatoyosi, Kantarjian, Hagop, Dezern, Amy, L Oconnell, Casey, Roboz, Gail, Busque, Lambert, Buckstein, Rena, Amin, Harshad, K Randhawa, Jasleen, Leber, Brian, Dao, Kim-Hien, Chan, Winny, Oganesian, Aram, Sano, Yuri, Mirakhur, Beloo, Keer, Harold, Garcia-Manero, Guillermo
Publicado 2023

P719: RANDOMIZED PHASE 1-2 STUDY TO ASSESS SAFETY AND EFFICACY OF LOW-DOSE (LD) ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS: IN...

por Garcia-Manero, Guillermo, Bachishvili, Kimo, A. Griffiths, Elizabeth, M. Zeidan, Amer, Traer, Elie, Saini, Lalit, Amin, Harshad, Mohan, Sanjay, Lübbert, Michael, Maness-Harris, Lori, M Foran, James, Selleslag, Dominik, Xicoy Cirici, Blanca, Aaron Pollyea, Daniel, Sallman, David, Al-Kali, Aref, Berdeja, Jesus, Kathrin Al-Ali, Haifa, Y Zhu, Nancy, Font Lopez, Patricia, Sanz Santillana, Guillermo, Santini, Valeria, A. Yimer, Habte, D Cripe, Larry, Priego, Victor, Odenike, Olatoyosi, Heyrman, Bert, Valcarcel, David, Vachhani, Pankit, Sano, Yuri, Mirakhur, Beloo, Oganesian, Aram, Keer, Harold, Yacoub, Abdulraheem
Publicado 2023